ABSTRACT The protein caldesmon inhibits actin-activated ATP hydrolysis of myosin and inhibits the binding of myosin*ATP to actin. A fragment isolated from a chymotryptic digest of caldesmon contains features of the intact molecule that make it useful as a selective inhibitor of the binding of myosin ATP complexes to actin without having the complexity of binding to myosin. The COOH-terminal 20 kDa region of caldesmon binds to actin with one-sixth the affinity of caldesmon with a stoichiometry of binding of one fragment per two actin monomers. This contrasts with the 1:6-9 stoichiometry of intact caldesmon. The binding of the 20 kDa fragments to actin is totally reversed by Ca2+-calmodulin and, like intact caldesmon, the 20 kDa fragments are competitive with the binding of myosin subfragments to actin. This competition with myosin binding is largely responsible for the inhibition of ATP hydrolysis, although both the fragments and intact caldesmon also reverse the potentiation of ATPase activity caused by tropomyosin. These polypeptides are useful both in defining the function of caldesmon and in studying the role of weakly bound cross-bridges in muscle.
INTRODUCTION
Caldesmon is associated with actin filaments in smooth muscle and nonmuscle cells and has been implicated in the regulation of motility (1) (2) (3) (4) (5) (6) (7) (8) . The inhibition of actin-activated myosin ATPase activity by caldesmon appears to occur by a mechanism different from that of the tropomyosin-troponin complex of striated muscle. Studies in solution (9, 10) and in single skeletal muscle fibers (6) have shown that tropomyosin-troponin alters the rate of transition from nonforce-producing cross-bridge states (weak binding states) to force producing states (strong binding states). In contrast, the results of several studies indicate that caldesmon inhibits the binding of myosin to actin. Thus, under conditions where caldesmon does not bind to myosin, caldesmon inhibits both the ATPase activity and binding to actin of skeletal myosin subfragment 1 (S-1) (11) and smooth heavy meromyosin (HMM) (12) (13) (14) . Caldesmon has also been shown to compete with the binding of various myosin subfragments to actin in the presence of pyrophosphate (11) and adenyl-5'-yl imidodiphosphate (AMP-PNP) (15) (16) (17) and in the absence of nucleotide (18, 19) . The binding of caldesmon to actin is reversed by antibodies that reverse the binding of S-1 ATP to actin (20) . Furthermore, the inhibition of ATPase activity by caldesmon occurs with a large change in the apparent Km (13, 21) .
We have shown that caldesmon may diffuse into singleskinned striated muscle fibers with subsequent inhibition of binding of weakly bound cross-bridges and the production of force (6, 10) . However, intact caldesmon has two properties that detract from its usefulness as a probe of cross-bridge function. First, the diffusion of caldesmon into single fibers is slow, requiring more than an hour to obtain full equilibration. Second, caldesmon binds to myosin, as well as to actin (15) , and this could cross-link actin to myosin and complicate the analysis of mechanical measurements of fibers. These problems can be avoided by using smaller proteolytic fragments of caldesmon that do not contain the myosinbinding region.
We have found that the most useful of the inhibitory actinbinding fragments originate at either Lys579 or Leu597 in the primary structure of caldesmon and terminate at or near the COOH terminus (19) . These fragments diffuse rapidly into fibers and inhibit the active force production of both skeletal (6) and smooth (7) muscle fibers. We now report the details of the interactions of these fragments that provide the basis for their use as probes of weak cross-bridge binding. The results presented here also help to define further the mechanism by which caldesmon inhibits actin-myosin interactions.
EXPERIMENTAL PROCEDURES
Skeletal actin was isolated from rabbit back and leg muscles by the method of Spudich and Watt (22) as modified by Eisenberg and Kielley (23) . Smooth muscle tropomyosin was isolated from turkey gizzards (24) . Calmodulin was purified from porcine brains (25) . Skeletal muscle myosin was isolated from the back and leg muscles of rabbits (26) , and chymotryptic S-1 was prepared by the method of Weeds and Taylor (27) . Caldesmon was isolated from turkey gizzards by the method of Bretscher (24) as modified by Velaz et al. (28) . Chymotryptic fragments were prepared according to our published procedure (19) . The 20 kDa fragments used correspond to combined peaks 1 through 3 of Fig. 2 of Chalovich et al. (19) . In one experiment a single 20 kDa fragment (equivalent to peak 2 of Fig. 2, Ref. 19 ) was used. Protein concentrations were determined by absorbance at 280 nm except for caldesmon, which was determined by the Lowry assay, using bovine serum albumin as a standard. The molecular weights used for calculation of protein concentrations were 120,000 (S-1), 42 ,000 (actin), 68,000 (tropomyosin), 16,500 (calmodulin), and 87,000 (caldesmon). The average molecular weight of the three actin-binding fragments of caldesmon was estimated to be 20,000 (19 Lys579 contain the radioactive label on Cys580. The binding of 14C-labeled caldesmon to actin was determined by the centrifugation method described previously (19, 28) under conditions given in the figure legends. Binding data were corrected for (a) the fraction of caldesmon that did not form a sediment even at saturating actin concentrations, (b) the amount of caldesmon that was present in the sediment in the absence of actin, and (c) the fraction of actin (5%) that did not form a sediment (28) . S-1 binding and caldesmon binding to caldesmon were sometimes measured simultaneously.
In these cases, S-1 binding was measured using the NH4+/EDTA ATPase assay as described by Chalovich and Eisenberg (29) .
ATPase assays
The ATPase activity of myosin skeletal S-1 was measured by the liberation of 32Pi from [32Pi]ATP as described earlier (29 Fig. 1 . While these four fragments can be resolved by high-performance liquid ion exchange chromatography, most experiments were performed using this mixture of fragments, since we have found no significant differences among these fragments. The binding of the 20 kDa fragments to actin was measured by cosedimentation of the 14C-labeled fragments with F-actin. Fig. 2 shows the results of binding to (40) fragments, derived from the 20 kDa fragments, contain a common region (U). The theoretical curve was fitted by using K = 0.63 X 106 M-1, w = 1, and n = 1.7. For the best fit of binding parameters to each data set see Table   1 .
ativity parameter w, which is involved in the binding of tandem caldesmon molecules (28) . Table 1 summarizes the data for the binding of the COOHterminal actin-binding fragment of caldesmon to actin in the presence and absence of smooth muscle tropomyosin. The value of n ranges from 1.7 to 2.6 (with an average of all experiments of 2.0) mol actin/mol of the caldesmon fragment. The value of X is between 1 and 2. The binding constant K varies from 0.2 to 0.7 X 106 M-1. The lack of effect of tropomyosin on the binding was not due to incomplete saturation of actin with tropomyosin since similar results were obtained at 0, 2.5, 3.5, and 6.0 ,uM tropomyosin. Furthermore, for comparison, an experiment has been included showing that tropomyosin increases the affinity of native caldesmon to actin from 0.9 to 1.9 X 106 M-1. In this case, 28 ,000), and the three small actin-binding polypeptides (Mr 22,000, 20,000, and 18,000). Thus, polypeptides from both the NH2-and COOH-terminal regions of caldesmon appear to bind to tropomyosin. In a separate experiment, purified 14C-labeled Mr 20,000 fragments were found to bind to the same column and elute in a NaCl gradient between 0.14 and 0.16 M (not shown). Fig. 4 shows the rate of ATP hydrolysis as a function of the amount of the caldesmon 20 kDa polypeptides bound to actin (open circles) and to actin-tropomyosin (closed circles). In the absence of tropomyosin, the rate of ATP hydrolysis decreases from 1.0 to 0.15 s-1 in nearly a linear fashion.
However, maximal inhibition ofATPase activity actually occurs at less than stoichiometric binding of fragments to actin.
In this experiment, maximum binding occurred with a stoichiometry of 1 fragment to 2-2.5 actin monomers, while maximum inhibition occurred at about a 1:3 stoichiometry. Although tropomyosin does not alter the binding of the 20 kDa fragments of caldesmon to actin, it does substantially enhance the degree of inhibition of actin-activated ATP hydrolysis. In the presence of tropomyosin, the deviation between full saturation of actin with the 20 kDa fragments and total inhibition of ATPase activity is large, as with intact caldesmon (33, 28) , with maximum inhibition occurring at about 50% saturation. This could occur if tropomyosin made caldesmon more effective in displacing bound S-1 or if there were additional reductions in the kcat. Tropomyosin, by itself, increases the actin activated ATPase activity of S-1 by about twofold under the conditions of this experiment, and the 20 kDa fragments apparently reverse this potentiating effect. A similar limiting ATPase rate is obtained in both the presence and absence of tropomyosin, which is 0.15 s-1 in excess of the rate of S-1 in the absence of actin. This feature was also observed with intact caldesmon (33, 28) . The inset to Fig. 4 shows the ATPase rates expressed relative to the rates in the absence of caldesmon to show the difference in caldesmon sensitivity caused by tropomyosin.
We had reported previously that intact caldesmon functions largely by competitively inhibiting the binding of S-1 ATP to actin (11, 14, 15, 18, 28) . Fig. 5 shows normalized values of the ATPase rate and S-1 ATP bound to actin as a function of the amount of the caldesmon fragment bound to actin. In this experiment, only a single 20 kDa fragment was used, which is the 20.1 kDa fragment (equivalent to peak 2 of Fig. 2, Ref. 19) . Furthermore, the Al isozyme of myosin S-1 was used, and the measurements were made at low ionic strength to increase the accuracy of measurement of S-1 binding. The inhibition ofATPase activity, shown here in the line) of binding were fit to these data (see Ref. 17) . The two models give similar fits at small values of n as in the present case. Fig. 7 shows that Ca2+-calmodulin displaces bound 20 kDa fragments from actin in a manner similar to that observed earlier with intact caldesmon (11) and the 7.3 kDa actin-binding fragment of caldesmon (19) . Fifty percent inhibition of binding is achieved at a calmodulin concentration of 25 and 12.5 ,uM for intact caldesmon (11) and the 20 kDa fragments, respectively.
DISCUSSION
The 20 kDa fragments of caldesmon are similar to intact caldesmon in their inhibition of acto-S-1 ATPase activity, their response to tropomyosin in this inhibition, and their competition with S-1 for binding to actin. Also of importance is the observation that the effects of the 20 kDa fragments are reversed by Ca2+-calmodulin since this provides a convenient way of neutralizing the effects of these probes of crossbridge action. Two advantages of the 20 kDa fragments are their more rapid diffusion into single muscle fibers (6) and their lack of interaction with myosin (14) . In contrast, intact caldesmon binds to skeletal HMM and even to some extent to skeletal S-1 at low ionic strength (15, 34 The affinity of the 20 kDa fragments for actin (K X w = 8 X 105 M-1) is one-sixth of that for intact caldesmon (28) and 18 times that of the 7.3 kDa fragment (19) . The This means that the 20 kDa fragments are good inhibitors of the weak binding interaction. It is also important that the 20 kDa fragments bind less tightly than the strong binding crossbridges. For example, K > 2 X 106 M1 at 60 mM ionic strength for HMM-AMP-PNP (35) . The S-1 ADP complex binds to actin with an even higher affinity (35) . Thus the 20 kDa fragments are selective inhibitors of the population of states known as weak binding states. This selectivity was demonstrated in single rabbit psoas fibers, where it was shown that caldesmon inhibits the attachment of crossbridges in the presence of ATP but not in the presence of pyrophosphate (6) .
A continuing question is whether caldesmon regulates ATPase activity solely by blocking the binding of myosin'ATP to actin or whether there is an additional component of regulation. The case for inhibition of myosin-ATP binding is based on direct binding measurements in solution (11, (14) (15) (16) on polarized fluorescence changes in ghost fibers (36) and by the effect of caldesmon on the kinetics of ATP hydrolysis (13, 21, 37 ). Recent studies have also shown that diffusion of caldesmon into rabbit psoas fibers results in a Calmodulin total' I M While there is now agreement that caldesmon competes with myosin binding, there is an active debate over the importance of this inhibition of binding in the presence of tropomyosin (38, 39) . It is clear from our past (19, 28, 33) and present work that caldesmon is a more effective inhibitor of ATPase activity in the presence of tropomyosin. Fig. 4 shows that the rate of ATPase activity is enhanced by tropomyosin and that this rapid ATPase activity is strongly inhibited by caldesmon. One-third as much bound caldesmon is required for 50% inhibition as in the absence of tropomyosin. There is cooperativity in the inhibition of ATPase activity that is seen only in the presence of tropomyosin. However, while caldesmon inhibits the cooperative activation of ATPase activity by smooth tropomyosin (12) there is considerable evidence that competition of binding remains a dominant feature in regulation (6, 11, 13, 14, 17, 21, 37 (28) , the 20 kDa fragment binds to about two actin monomers (present study), and the 7.3 kDa fragment, which is the NH2 terminal region of the 20 kDa fragment, binds to one actin monomer (19) . We would have predicted, from these results, that the COOH-terminal half of the 20 kDa fragment would also bind to a single actin monomer. However, a CNBr fragment of caldesmon, which is essentially the COOH-terminal region of the 20 kDa fragment, is reported to bind to actin with a 1:7 stoichiometry (40), much like intact caldesmon. We cannot explain this result at present.
Caldesmon has been shown earlier to bind to tropomyosin (32) , and this has been localized to the 38 kDa COOHterminal region (41) . We have observed that fragments from both the NH2-and COOH-terminal regions of caldesmon bind to tropomyosin, although it is not clear if these are both physiologically significant interactions. Likely regions for the tropomyosin-binding sites are the two tropomyosinbinding consensus sequences at residues 508-565 and 592-623 (42) (43) (44) . Our 20 kDa fragments contain this second region. Watson et al. (45) have suggested that residues 142-227 of tropomyosin are involved in the binding of intact caldesmon but the site to which this region of tropomyosin binds has not been identified. Although the 20 kda caldesmon fragments bind to tropomyosin, there is little effect of tropomyosin on the binding of caldesmon to actin. This is not totally unexpected since earlier studies have shown that tropomyosin has a relatively small (about threefold) effect on the binding of intact caldesmon to actin (28) , even though caldesmon binds as tightly to tropomyosin in solution (46) as caldesmon binds to actin (28) . These results indicate that the caldesmon-binding site on tropomyosin may be partially inaccessible in the presence of actin.
In conclusion, the 20 kDa actin-binding fragments of caldesmon have the inhibitory properties normally associated with caldesmon but lack the complication of binding to myosin. These fragments are well suited for perturbing the "weak" binding of myosin to actin that occurs during ATP hydrolysis both in solution and in muscle.
